Label: CALCIUM CARBONATE suspension
- NDC Code(s): 0054-3117-63
- Packager: Hikma Pharmaceuticals USA Inc.
- Category: HUMAN OTC DRUG LABEL
DISCLAIMER: Most OTC drugs are not reviewed and approved by FDA, however they may be marketed if they comply with applicable regulations and policies. FDA has not evaluated whether this product complies.
Drug Label Information
Updated December 19, 2022
If you are a healthcare professional or from the pharmaceutical industry please visit this version.
- Download DRUG LABEL INFO: PDF XML
- Official Label (Printer Friendly)
- CALCIUM CARBONATE Oral Suspension (not USP)
- Supplement Facts
- Active Ingredient
- Purpose
- Keep Out of Reach of Children
- Uses
- Warnings
- Directions
- Storage and Handling
- Inactive Ingredients
- Questions or Comments
- Package/Label Principal Display Panel
-
INGREDIENTS AND APPEARANCE
CALCIUM CARBONATE
calcium carbonate suspensionProduct Information Product Type HUMAN OTC DRUG Item Code (Source) NDC:0054-3117 Route of Administration ORAL Active Ingredient/Active Moiety Ingredient Name Basis of Strength Strength CALCIUM CARBONATE (UNII: H0G9379FGK) (CALCIUM CATION - UNII:2M83C4R6ZB) CALCIUM CARBONATE 1250 mg in 5 mL Inactive Ingredients Ingredient Name Strength SORBITOL (UNII: 506T60A25R) 1-PROPOXY-2-PROPANOL (UNII: 152BY1743W) XANTHAN GUM (UNII: TTV12P4NEE) METHYLPARABEN (UNII: A2I8C7HI9T) SPEARMINT (UNII: J7I2T6IV1N) SODIUM HYPOCHLORITE (UNII: DY38VHM5OD) Packaging # Item Code Package Description Marketing Start Date Marketing End Date 1 NDC:0054-3117-63 500 mL in 1 BOTTLE; Type 0: Not a Combination Product 11/18/2004 05/31/2024 Marketing Information Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date OTC monograph final part331 11/18/2004 05/31/2024 Labeler - Hikma Pharmaceuticals USA Inc. (080189610) Establishment Name Address ID/FEI Business Operations West-Ward Columbus Inc. 058839929 MANUFACTURE(0054-3117)